US Stock MarketDetailed Quotes

NVNO enVVeno Medical

Watchlist
  • 3.240
  • -1.260-28.00%
Close Sep 27 16:00 ET
  • 3.390
  • +0.150+4.63%
Post 19:51 ET
43.19MMarket Cap-2347P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $enVVeno Medical (NVNO.US)$
    enVVeno Medical Corporation Announces Pricing of $15.0 Million Public OfferingenVVeno Medical (NASDAQ:NVNO) has announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock (or pre-funded warrants) at $3.50 per share. The company expects to receive gross proceeds of approximately $15.0 millionfrom the offering, excluding underwriting discounts and other expenses. The offering is expected to close around September 30, 2024.
    The co...
    $enVVeno Medical (NVNO.US)$
    enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
    enVVeno Medical has made significant progress in its FDA premarket approval (PMA) application for the VenoValve, a surgical replacement venous valve. The company has successfully submitted, and the FDA has approved, four out of five modules required for the PMA application. The fifth and final module, containing clinical data from the SAVVE U.S. pivotal trial, is expecte...
    $enVVeno Medical (NVNO.US)$
    New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
    enVVeno Medical announced the presentation of new interim venous ulcer healing data from the VenoValve U.S. pivotal trial at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024. The data, presented by Dr. Cassius Iyad Ochoa Chaar of Yale School of Medici...
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data